Edge Therapeutics Inc (EDGE):企業の財務・戦略的SWOT分析

◆英語タイトル:Edge Therapeutics Inc (EDGE) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14978
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neurological conditions. Its lead pipeline products include EG-1962, a proprietary formulation, which is used to treat aneurysmal subarachnoid hemorrhage, is in Phase 3 clinical trials and EG-1964 is in preclinical stage used to prevent recurrent chronic subdural hematoma. The company’s Precise is a proprietary, programmable, biodegradable polymer-based development platform develops products for the treatment of acute neurological conditions. Edge Therapeutics is headquartered in Berkeley Heights, New Jersey, the US.

Edge Therapeutics Inc Key Recent Developments

Feb 21,2019: Edge Therapeutics announces full year 2018 financial results
Nov 01,2018: Edge Therapeutics reports third quarter 2018 financial results
Aug 01,2018: Edge Therapeutics Reports Second Quarter 2018 Financial Results
May 01,2018: Edge Therapeutics Announces First Quarter 2018 Financial Results
Apr 30,2018: Edge Therapeutics Announces Review of Strategic Alternatives

This comprehensive SWOT profile of Edge Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Edge Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Edge Therapeutics Inc – Key Information
Edge Therapeutics Inc – Overview
Edge Therapeutics Inc – Key Employees
Edge Therapeutics Inc – Key Employee Biographies
Edge Therapeutics Inc – Key Operational Heads
Edge Therapeutics Inc – Major Products and Services
Edge Therapeutics Inc – History
Edge Therapeutics Inc – Company Statement
Edge Therapeutics Inc – Locations And Subsidiaries
Edge Therapeutics Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Edge Therapeutics Inc – Business Description
Edge Therapeutics Inc – Corporate Strategy
Edge Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Edge Therapeutics Inc – Strengths
Edge Therapeutics Inc – Weaknesses
Edge Therapeutics Inc – Opportunities
Edge Therapeutics Inc – Threats
Edge Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Edge Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Edge Therapeutics Inc, Key Information
Edge Therapeutics Inc, Key Ratios
Edge Therapeutics Inc, Share Data
Edge Therapeutics Inc, Major Products and Services
Edge Therapeutics Inc, History
Edge Therapeutics Inc, Key Employees
Edge Therapeutics Inc, Key Employee Biographies
Edge Therapeutics Inc, Key Operational Heads
Edge Therapeutics Inc, Other Locations
Edge Therapeutics Inc, Subsidiaries
Edge Therapeutics Inc, Key Manufacturing facilities
Edge Therapeutics Inc, Key Competitors
Edge Therapeutics Inc, SWOT Analysis
Edge Therapeutics Inc, Ratios based on current share price
Edge Therapeutics Inc, Annual Ratios
Edge Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Edge Therapeutics Inc, Performance Chart
Edge Therapeutics Inc, Ratio Charts

★海外企業調査レポート[Edge Therapeutics Inc (EDGE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hitachi Construction Machinery Co., Ltd. (6305):企業の財務・戦略的SWOT分析
    Hitachi Construction Machinery Co., Ltd. (6305) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • The Cheesecake Factory Incorporated:企業の戦略・SWOT・財務情報
    The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Energiekontor AG (EKT):企業の財務・戦略的SWOT分析
    Summary Energiekontor AG (Energiekontor) is a renewable energy company that develops and operates offshore wind farms. It offers services which include construction, designing, engineering, planning, operation, and management of wind farms. The company also provides project financing, project manage …
  • St. Jude Children’s Research Hospital Inc-製薬・医療分野:企業M&A・提携分析
    Summary St. Jude Children’s Research Hospital Inc (St. Jude) is a healthcare service provider that offers research and clinical care services for children with catastrophic diseases. The hospital provides treatment programs such as brain tumors, leukemia, infectious diseases, immunodeficiency diseas …
  • Pro-Dex Inc (PDEX):製品パイプライン分析
    Summary Pro-Dex Inc (Pro-Dex) is a medical device company that manufactures and markets surgical devices. The company’s products comprise motion control, finished medical devices, plastic injection molding, micro air-motors, dental products, and torque wrenches. Its dental products include DLS handp …
  • Imerys SA:企業のM&A・事業提携・投資動向
    Imerys SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Imerys SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • China Grand Pharmaceutical and Healthcare Holdings Ltd (512):医療機器:M&Aディール及び事業提携情報
    Summary China Grand Pharmaceutical and Healthcare Holdings Ltd (China Grand) is an investment holding company that develops, manufacture and distributes pharmaceutical preparations, medical devices and pharmaceutical intermediates, specialized raw materials, and healthcare products. The company prov …
  • Belk Inc:戦略・SWOT・企業財務分析
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • HDI-Global SE:企業の戦略・SWOT・財務情報
    HDI-Global SE - Strategy, SWOT and Corporate Finance Report Summary HDI-Global SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Pharmaxis Ltd (PXS):企業の財務・戦略的SWOT分析
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company provides products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves …
  • Mega First Corporation Bhd (MFCB):企業の財務・戦略的SWOT分析
    Summary Mega First Corporation Bhd (MFCB) is a diversified company. The company operates through its business divisions such as power generation, resources, and property development and investment. Its power generation business builds, owns, operates and maintains coal-fired heat and power plant. MF …
  • CIC Insurance Group Limited (CIC):企業の財務・戦略的SWOT分析
    CIC Insurance Group Limited (CIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Metagenics Inc:企業の戦略的SWOT分析
    Metagenics Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Intarcia Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that focuses on the development of therapies through its proprietary Medici Drug Delivery System, a subcutaneous delivery system to treat chronic conditions. The company’s product candidate includ …
  • Methaq Takaful Insurance Company:企業の戦略・SWOT・財務情報
    Methaq Takaful Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Methaq Takaful Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • MBNA Ltd:企業の戦略・SWOT・財務情報
    MBNA Ltd - Strategy, SWOT and Corporate Finance Report Summary MBNA Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Zelan Bhd:企業の戦略・SWOT・財務情報
    Zelan Bhd - Strategy, SWOT and Corporate Finance Report Summary Zelan Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Xintela AB (XINT):企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also o …
  • InspireMD Inc (NSPR):企業の財務・戦略的SWOT分析
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • Champions Oncology Inc (CSBR):企業の財務・戦略的SWOT分析
    Summary Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s technology platform is an approach based upon the implantation of primary human tumor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆